![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Nationwide Estimation of Eligibility for Endovascular Thrombectomy Based on the DAWN Trial |
Keon-Joo Lee, Beom Joon Kim, Dong-Eog Kim, Wi-Sun Ryu, Moon-Ku Han, Joon-Tae Kim, Kang-Ho Choi, Ki-Hyun Cho, Jae-Kwan Cha, Dae-Hyun Kim, Hyun-Wook Nah, Jong-Moo Park, Kyusik Kang, Soo Joo Lee, Jae Guk Kim, Mi-Sun Oh, Kyung-Ho Yu, Byung-Chul Lee, Keun-Sik Hong, Yong-Jin Cho, Tai Hwan Park, Kyung Bok Lee, Jun Lee, Ji Sung Lee, Juneyoung Lee, Hee-Joon Bae, |
J Stroke. 2018;20(2):277-279. Published online May 31, 2018 DOI: https://doi.org/10.5853/jos.2018.00836 |
Nationwide Estimation of Eligibility for Endovascular Thrombectomy Based on the DAWN Trial DAWN: Another Boost for Endovascular Thrombectomy in Patients with Acute Ischemic Stroke Reperfusion of the Ischaemic Brain by Endovascular Thrombectomy and Thrombolysis Thrombectomy for Acute Internal Carotid Thrombosis: Five Thrombectomy Devices Compared Midterm Outcomes of Pharmacomechanical Thrombectomy in the Treatment of Lower Extremity Deep Vein Thrombosis With a Rotational Thrombectomy Device tPA an Unnecessary Adjunct to Endovascular Thrombectomy? An Analysis of the DIRECT-MT Trial Eligibility for the Surgical Trial in Intracerebral Hemorrhage II Study in a Population-based Cohort Representativeness of EXPLORER-HCM trial and prevalence of eligibility criteria for Mavacamten in a nationwide cohort Long-Term Outcomes of Acute Endovascular Thrombectomy: Tokyo/tama-Registry of Acute Endovascular Thrombectomy (TREAT) Hybernia post-mechanical thrombectomy – Endovascular cerebral hypothermia trial in acute ischemic stroke (post-mtech trial) |